Michael Lim, MD
Disclosures: Consulting Fee-Tocagen, VBI, InCephalo Therapeutics, Pyramid Bio, Merck, BMS, Inisghtec, Biohaven, Sanionia, Hemispherian, Black Diamond Therapeutics, Novocure, Noxxon|Contracted Research-Arbor, BMS, Accuray, Tocagen, Biohaven, Kyrin-Kyowa, Biohaven, Urogen|Stock Holder-Egret Therapeutics, Pyramid Bio|Royalty-Focused Radiation, Checkpoint Inhibitors Local Chemotherapy, Checkpoint Inhibitors Checkpoints for Neuro-Inflammation - 12/06/2021
No Bio Available.